Africa Sexual Transmitted Infections Diagnostics Market: By Disease Type, By Diagnostic Test Type, By End User, and Country

Africa Sexual Transmitted Infections (STI) Diagnostics Market: By Disease Type (Chlamydia and Gonorrhea, Trichomoniasis and Mycobacterium Genitalis, Syphilis, Vulvovaginal Candidiasis, Bacterial Vaginosis, Group B Streptococcus, and Herpes Simplex Virus), By Diagnostic Test Type (Cultural Test and PCR Test), By End User (Public and Private), and Country

Africa Sexual Transmitted Infections Diagnostics Market size was valued at US$ 71.6 million in 2023 and grew at 4.6 % CAGR over the historical years (2019 - 2023). The market is projected to reach US$ 108.5 mllion by 2030 at a CAGR of 7.6 %.  The market is driven by several key factors which are the rising prevalence of STDs, increasing awareness, improved healthcare infrastructure, and technological advancements. The World Health Organization has estimated that every year in Africa there are 3.5 million cases of syphilis, 15 million cases of chlamydial disease, 16 million cases of gonorrhea, and 30 million cases of trichomoniasis.

In Africa, the testing for STD treatment and diagnosis is done for only symptomatic, and many asymptomatic patients may go untreated and undiagnosed because they don’t show any symptoms. In some African countries, they mostly use cultural methods to diagnose the STI infections in the region.  South Africa is the leading country in the African STD diagnostics market followed by Nigeria. In terms of value, Africa generated US$ 26.1 million for culture tests and US$ 45.5 million in revenue for PCR tests in 2023 and by 2029, Government Funding,  Public-Private Partnerships, and Mobile Health are the opportunities in the market. Point-of-care testing, Self-Testing, and Home-Based Care are the trends in the market, due to opportunities and trends in the STD diagnostics market having significant growth in the upcoming years. However, the constraints limit the growth of the market such as limited healthcare resources, stigma, and the high cost of testing are the constraints in the African STD diagnostics market. By understanding these drivers, constraints, opportunities, and trends, stakeholders in the African STD diagnostics market can strategize for future growth and make a positive contribution to public health efforts in the region.

Africa Sexual Transmitted Infections Diagnostics Market Key Developments:
  • In May 2022, Dickinson & Company and Becton launched the BD COR MX instrument, a new fully automated, high-throughput molecular diagnostic platform for infectious diseases.

Africa STD Diagnostics Market Dynamics

The rising prevalence of STDs such as syphilis, gonorrhea, and chlamydia is driving up demand for STD testing and diagnostics. There is a growing awareness of the importance of sexual health in Africa, and people are more likely to get tested for STDs. This is due to factors such as government initiatives, educational campaigns, and the work of NGOs. The healthcare infrastructure in Africa is gradually improving, with more clinics and hospitals being built and more healthcare workers being trained. This is making it easier for people to access STD testing and diagnostics. New technologies are emerging that are making STD testing faster, easier, and more affordable. This includes point-of-care tests that can be used in clinics or even at home. There is an initial for increasing government funding for STD prevention and control programs. This would help to improve access to testing and diagnostics, as well as raise awareness of the importance of sexual health.

Africa Sexual Transmitted Infections Diagnostics Market Segmentation Analysis

Report Benchmarks

Details

Market Size in 2023

US$ 71.6 million

By Disease Type

  • Chlamydia and Gonorrhea
  • Trichomoniasis and Mycobacterium Genitalis
  • Syphilis
  • Vulvovaginal Candidiasis
  • Bacterial Vaginosis
  • Group B Streptococcus
  • Herpes Simplex Virus

By Diagnostic Test Type

  • Cultural Test
  • PCR Test

By End User

  • Public
  • Private

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.

Download Free Sample Report

Frequently Asked Questions

The STI Diagnostics Market was valued at US$ 71.6 million in 2023 and is projected to reach US$ 108.5 million by 2030, growing at a CAGR of 7.6%.

• Rising Prevalence of STDs
• Increasing Awareness
• Improved Healthcare Infrastructure
• Technological Advancements

• Government Funding
• Public-Private Partnerships
• Mobile Health

• Point-of-care testing
• Self-Testing
• Home-Based Care

South Africa is the dominant region in the Africa STD Diagnostics Market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

Key Market Players

  • Abbott Laboratories
  • Hoffmann-La Roche Ltd.
  • bioMérieux SA
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Quidel Corporation
  • Hologic, Inc.
  • Bio-Rad Laboratories, Inc.
  • QIAGEN
  • BD
  • DiaSorin S.p.A

Related Industry Reports